Subsequent experiments demonstrated that neutralizing OSM activity with a specific antibody markedly suppressed N‐CM‐induced STAT3 activation and inhibited the EMT process in hepatoma cells (Figure 6G). The gene discussed is STAT3; the disease is hepatocellular carcinoma.